Scienture Holdings, Inc.

Stock Chart, Company Information, and Scan Results

$1.94(as of Jul 31, 3:58 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Scienture Holdings, Inc. Company Information, Fundamentals, and Technical Indicators

Stock Price$1.94
Ticker SymbolSCNX
ExchangeNasdaq
SectorHealthcare
IndustryPharmaceutical Retailers
Employees14
CountyUSA
Market Cap$27.1M
EBIDTAUnknown
10-Day Moving Average2.06
P/E Ratio-1.16
20-Day Moving Average1.85
Forward P/E Ratio21.83
50-Day Moving Average1.33
Earnings per Share-20.22
200-Day Moving Average3.57
Profit Margin-29,869.34%
RSI58.97
Shares Outstanding8.6M
ATR0.16
52-Week High10.23
Volume87,623
52-Week Low0.69
Most Recent Support Level1.90
Book Value81.2M
Most Recent Resistance Level2.11
P/B Ratio0.22
Upper Keltner2.21
P/S Ratio119.99
Lower Keltner1.49
Debt-to-Equity Ratio2.21
Next Earnings DateUnknown
Cash Surplus-5.4M
Next Ex-Dividend DateUnknown

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is based in Tampa, Florida.

Scienture Holdings, Inc. In Our Stock Scanner

As of Jul 31, 2025
example chart graphic
Scan Name: Bull FlagScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.